Yan Cheng, Ph.D.
Yan Cheng, Ph.D., is an instructor for the UAMS Winthrop P. Rockefeller Cancer Institute’s Myeloma Center.
Cheng, who joined the Myeloma Center team in 2021, conducts translational research, including identifying the biology of multiple myeloma risk genes. Her research focuses on unravelling the mechanisms of resistance to therapy to help develop new immune treatments for various forms of myeloma.
Cheng, who works under the guidance of Fenghuang (Frank) Zhan, M.D., Ph.D., in maintaining the center’s mass cytometry, is a mentor to several students. An alumna of China Pharmaceutical University, Cheng received the 2022 Winthrop P. Rockefeller Cancer Institute Research Retreat Outstanding Postdoc Poster Award.
Fumou Sun, Ph.D.
Fumou Sun, Ph.D., is an instructor for the UAMS Department of Internal Medicine and the Winthrop P. Rockefeller Cancer Institute’s Myeloma Center.
He earned his doctorate from China Pharmaceutical University in the spring of 2019.
His primary role for the Myeloma Center is finding and identifying potential myeloma treatment targets and designing novel therapeutic strategies.
Additionally, Sun has used his expertise of antibody engineering and multiple myeloma immunology to establish the chimeric antigen receptor (CAR) T-cell platform for the Myeloma Center lab. Sun is the creator of the antibody screening platform currently used by the facility.
Sun, who has been with the center since August 2021, works under the tutelage of Fenghuang (Frank) Zhan, M.D., Ph.D. Due to his excellence in research, Sun earned the 2022 American Society of Hematology (ASH) Abstract Achievement Award and has been invited by the ASH Program Committee for presentation in an oral session at the 64th ASH Annual Meeting.